REMODEL - Renal mode of action of semaglutide in patients with type 2 diabetes and chronic kidney disease
Details
Age
Adult
Type of Study
Treatment
Locations
Barbara Davis Center
Childrens Hospital Colorado
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Petter Bjornstad, MD
Study ID
Protocol Number: 21-2645
More information available at ClinicalTrials.gov: NCT04865770
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers